Sutro Biopharma, Inc. (STRO)

Sutro Biopharma, Inc. in the Healthcare sector is trading at $19.10 with a market capitalization of $317M. Wall Street consensus targets $47.23 (13 analysts), implying a +147.3% move over the next 12 months. The stock is currently 56% below its 52-week high of $43.85, remaining 14.2% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 30 is oversold, raising the odds of a near-term bounce. The Whystock Score of 35/100 signals elevated caution as multiple indicators diverge.